A fund manager's calculus about which sectors deserve more capital
In the quiet arithmetic of capital allocation, India's largest flexi cap fund has spoken its convictions for September: trust in banks, curiosity about wellness and energy, and a measured retreat from automobiles. Parag Parikh Flexi Cap Fund, stewarding Rs 1.19 lakh crore across 27 stocks, deepened its faith in the financial sector while multiplying its Zydus Wellness position fivefold and walking away entirely from IPCA Laboratories. These are not merely transactions — they are a professional reading of where India's economic momentum may be gathering.
- The fund's decisive pivot toward four major banks — Axis, HDFC, ICICI, and Kotak — signals growing conviction that India's financial sector is positioned to outperform in the near term.
- A fivefold multiplication of Zydus Wellness shares, from 44 lakh to 2.20 crore, stands as the month's most dramatic single move and points to a sharp new bet on consumer healthcare.
- The complete exit from IPCA Laboratories and the trimming of Maruti Suzuki suggest the fund managers have quietly lost confidence in pharmaceutical and automobile holdings they once favored.
- Assets under management climbed from Rs 1.15 lakh crore to Rs 1.19 lakh crore in a single month, reflecting continued investor trust even as the portfolio narrows from 28 to 27 stocks.
- A structural change arriving October 31 — the introduction of an IDCW payout option — opens the fund to income-seeking investors for the first time, broadening its appeal beyond pure growth mandates.
In September, Parag Parikh Flexi Cap Fund made a series of portfolio moves that collectively tell a story about where its managers see India's economic opportunity concentrating. The fund added meaningfully to positions in Axis, HDFC, ICICI, and Kotak Mahindra banks, as well as ITC, while rotating away from automobiles and exiting a pharmaceutical holding entirely. The asset base grew to Rs 1.19 lakh crore, and the portfolio tightened to 27 stocks.
The most striking single move was in Zydus Wellness, where the fund multiplied its holding roughly fivefold — from 44 lakh shares in August to 2.20 crore shares by month's end. Beyond that headline addition, the fund also built positions in Power Grid Corporation of India, Indian Energy Exchange, and several healthcare names including Cipla and Dr Reddy's Laboratories. The pattern points toward a deliberate rotation into healthcare, utilities, and energy infrastructure.
On the exit side, the fund sold down Maruti Suzuki modestly but meaningfully, and made a clean break from IPCA Laboratories, liquidating its entire 2.18 lakh share position. Whether driven by lost conviction or redeployment of capital, these departures sharpen the fund's sectoral focus.
Managed since 2013 by a seven-person team led by Rajeev Thakkar and benchmarked against the NIFTY 500, the fund has long pursued long-term capital growth through active equity management. A separate announcement adds a new dimension: starting October 31, the fund will offer an IDCW option alongside its existing growth structure, allowing investors to receive periodic income distributions rather than automatic reinvestment. The underlying portfolio remains unchanged, but the choice now belongs to the investor.
In September, Parag Parikh Flexi Cap Fund—India's largest active flexi cap fund by assets under management—made a deliberate shift in its portfolio that signals where its managers see opportunity in the Indian market right now. The fund added to positions in four major banks: Axis, HDFC, ICICI, and Kotak Mahindra. It also increased its stake in ITC. At the same time, it trimmed exposure to Maruti Suzuki and made a complete exit from IPCA Laboratories, a pharmaceutical company it had held.
The fund's asset base grew to Rs 1.19 lakh crore by month's end, up from Rs 1.15 lakh crore in August. The portfolio now holds 27 stocks, down one from the previous month. The moves reveal a fund manager's calculus about which sectors and companies deserve more capital and which deserve less—a window into how professional investors are reading the moment.
The largest single addition was striking: the fund bought 1.76 crore shares of Zydus Wellness, bringing its total holding to 2.20 crore shares in September from 44 lakh in August. That's a multiplication by five. Beyond that, the fund added nearly 99 lakh shares of Power Grid Corporation of India and 72 lakh shares of Indian Energy Exchange. Seven other stocks also saw increased holdings: Cipla, Dr Reddy's Laboratories, EID Parry India, Zydus Lifesciences, and others. The smallest addition was 3.61 lakh shares of Zydus Lifesciences. The pattern suggests the fund is rotating toward healthcare, utilities, and energy infrastructure while pulling back from automobiles.
On the other side of the ledger, the fund sold nearly 50,000 shares of Maruti Suzuki, reducing its position from 27.46 lakh shares in August to 26.96 lakh in September. The reduction was modest in percentage terms but meaningful as a signal. More decisive was the complete exit from IPCA Laboratories, where the fund sold 2.18 lakh shares and walked away entirely. These moves suggest the fund managers have lost conviction in these holdings or found better uses for the capital elsewhere.
Parag Parikh Flexi Cap Fund has been managed since its launch in May 2013 by a team of seven: Rajeev Thakkar, Raunak Onkar, Raj Mehta, Rukun Tarachandani, Tejas Soman, Mansi Kariya, and Aishwarya Dhar. The fund is benchmarked against the NIFTY 500 and aims to generate long-term capital growth through an actively managed portfolio of equities and equity-related securities, with some flexibility to invest in foreign equities and debt.
Separately, the fund house announced a structural change to the fund effective October 31. Until now, investors could choose between direct and regular plans, but both offered only a growth option—meaning dividends or distributions were reinvested automatically. Starting in October, the fund will introduce an IDCW option, which stands for Income Distribution cum capital withdrawal. This gives investors a choice: they can receive payouts of income distributions, or they can reinvest them. The default will remain growth with automatic reinvestment, but investors will now have agency to choose otherwise. The NAVs of the different options will be calculated separately, though the underlying portfolio remains the same. This change expands the fund's appeal to investors who want periodic income rather than pure capital appreciation.
Citas Notables
The fund will offer the IDCW option as well, in addition to the growth option provided earlier, with payout and reinvestment facilities.— Parag Parikh Flexi Cap Fund notice cum addendum
La Conversación del Hearth Otra perspectiva de la historia
Why would a fund manager add so heavily to Zydus Wellness all at once? That's a five-fold increase in one month.
It suggests conviction. Either the stock became undervalued relative to its prospects, or the fund manager believes the company is positioned well for what's coming next. You don't multiply a position that size on a whim.
And the banks—four of them at once. Is that a sector bet or individual stock selection?
Probably both. Banks are sensitive to interest rates and credit cycles. If the managers believe rates are stabilizing or credit demand is about to pick up, they'd want exposure across the sector. But they're also choosing which banks, which means they see differences in how well each will perform.
What does it mean that they exited IPCA entirely but only trimmed Maruti?
Complete exits are rare and deliberate. It means they've lost faith in IPCA's story. With Maruti, they're not abandoning the position—they're just reducing it. Maybe they think the auto sector will be okay, but they don't need as much exposure, or they found better uses for that capital.
The new IDCW option—why does that matter to investors?
Control. Until now, if you invested in this fund, you got growth only. Your distributions were automatically reinvested. Now you can choose to take the money out. That appeals to retirees or anyone who wants income, not just capital appreciation.
Does the fund's size—Rs 1.19 lakh crore—make it harder to move?
Absolutely. At that scale, every trade moves the market a little. The managers have to be thoughtful about position sizing. They can't just load up on small-cap stocks. These moves in large-cap banks and established companies make sense given the fund's weight.